Others

Artificial Skin (Skin Efficacy Test)


Organism	Human
Product Type	Artificial Skin
Tissue	Skin
Disease

Applications

Others

Artificial Skin OECD TG 431


Organism	Human
Product Type	Artificial Skin
Tissue	Skin
Disease

Applications

Others

Artificial Skin OECD TG 439


Organism	Human
Product Type	Artificial Skin
Tissue	Skin
Disease

Applications

Others

Artificial cornea(RhCE) OECD TG 437

Comprehensive Testing Services: Our institution is the only certified testing and certification body in Korea that offers a one-stop service from alternative animal testing to clinical skin trials for cosmetics, medical, bio, and chemical products.
Specialized Non-Clinical and Clinical Trials: We specialize in non-clinical trials focusing on alternative animal testing and efficacy testing, as well as clinical skin trials to evaluate the safety and efficacy of cosmetic ingredients and products.
State-of-the-Art Facilities and Equipment: Utilizing cutting-edge facilities and equipment, we provide highly reliable data, ensuring the utmost accuracy and trust in our safety and efficacy assessments.


Organism	Bovine
Product Type	Tissue
Tissue	Cornea
Disease

Applications

Eye irritation test - BCOP assay (OECD TG 437)

Eye irritation test is in accordance with the Ministry of Food and Drug Safety guidelines, assesses eye irritation potential using bovine corneas.

In vitro eye irritation test (OECD TG492)

Reconstructed human Cornea-like Epithelium (RhCE) test method for identifying chemicals not requiring classification and labelling for eye irritation or serious eyedamage.

Cancer Organoid

Endometrial Cancer Organoid

Accurate Predictions and Personalized Treatment
▶ Endometrial cancer organoids replicate patient tumors for precise predictions and tailored treatments.
Efficient Drug Testing and Time-Saving
▶ Rapid drug testing with endometrial cancer organoids reduces research time and enhances reliability.
Advanced Research and Innovation
▶ Cutting-edge organoid models surpass traditional methods, advancing cancer research and treatment solutions.


Organism	Human
Product Type	Organoid
Tissue	Endometrial cancer
Disease	Endometrial cancer

Applications

Oncology

The oncology drug efficacy evaluation platform is based on patient-derived organoids(PDOs).
This platform allows for the assessment of the efficacy of oncology agents and immunotherapeutics by utilizing a co-culture system with immune cells from the tumor microenvironment.

Immuno-Oncology

This provides a solution for assessing the effectiveness of immunotherapeutic agents targeting cytotoxic T cells in co-culture with cancer organoids.

Tumormicroenvironment

CAFs promote cancer invasion and metastasis, potentially inducing resistance to anticancer drugs. Considering these functions of CAFs is crucial for accurately assessing the efficacy of anticancer drugs and developing strategies to address these challenges.

Cancer Vaccine

Lead the future of treatment with our innovative cancer vaccine and mRNA therapy platform.
Discover advanced solutions that provide better health and hope through our cutting-edge technology and scientific approach

Cancer Organoid

Hepatocarcinoma Cancer Organoid

Precise Tumor Environment Replication
▶ Our Hepatocarcinoma Cancer Organoid model accurately simulates the patient's tumor in a 3D environment, ensuring precise research outcomes.
Personalized Treatment Development
▶ Utilize our model to develop personalized treatments tailored to the unique genetic and cancer characteristics of each patient.
Innovative Drug Development
▶ Boost drug development success with our model, saving time and costs by using actual tumor tissues for accurate predictions.


Organism	Human
Product Type	Organoid
Tissue	Hepatocellular carcinoma, Total necrotic lesion
Disease	Hepatocellular carcinoma

Applications

Oncology

Immuno-Oncology

This provides a solution for assessing the effectiveness of immunotherapeutic agents targeting cytotoxic T cells in co-culture with cancer organoids.

Tumormicroenvironment

Cancer Vaccine

Artificial Skin

Realistic Tissue Simulation ▶ Our Artificial Skin closely replicates human skin properties, enhancing the accuracy and reliability of skin tests.
Broad Testing Applications ▶ Suitable for various tests like skin corrosion and irritation, our Artificial Skin is an excellent tool for comprehensive safety and efficacy assessments.
Ethical and Sustainable ▶ It provides an ethical alternative to animal testing, promoting sustainability and compliance with modern ethical standards.


Organism	Human
Product Type	Organoid + T cell + Macrophage
Tissue	iPSC, ASC
Disease

Applications

Fabry’s disease modeling

Inflammatory Bowel Disease (IBD) refers to a chronic condition characterized by inflammation within the gastrointestinal tract, causing inflammation of the intestinal walls.

Intestinal fibrosis model (3D)

Lambda's Intestinal Fibrosis Model addresses these challenges by leveraging high mimetic human intestinal organoids to create a model of inflammatory bowel diseases.

Probiotic adhesion assay (2D)

Lambda provides a 2D platform for gut attachment and allows for the evaluation of probiotics efficacy through gut attachment analysis.

Host-Microbiome study (3D)

Lambda's highly human-mimicking intestinal organoids enable realistic research on the gastrointestinal system and interactions between cells and microorganisms, serving as a versatile tool for drug development and disease research.

Drug absorption assay(2D)

Lambda provides drug absorption evaluation through drug (sample) permeability analysis using hPSC-derived human functional intestinal epithelial cells (hIEC).

Others

Bovine Cornea OECD TG 492

Comprehensive Testing Services: Our institution is the only certified testing and certification body in Korea that offers a one-stop service from alternative animal testing to clinical skin trials for cosmetics, medical, bio, and chemical products.
Specialized Non-Clinical and Clinical Trials: We specialize in non-clinical trials focusing on alternative animal testing and efficacy testing, as well as clinical skin trials to evaluate the safety and efficacy of cosmetic ingredients and products.
State-of-the-Art Facilities and Equipment: Utilizing cutting-edge facilities and equipment, we provide highly reliable data, ensuring the utmost accuracy and trust in our safety and efficacy assessments.


Organism	Bovine
Product Type	Tissue
Tissue	Cornea
Disease

Applications

In vitro eye irritation (OECD TG 437)

Eye irritation test is in accordance with the Ministry of Food and Drug Safety guidelines, assesses eye irritation potential using bovine corneas.

In vitro eye irritation test (OECD TG492)

Reconstructed human Cornea-like Epithelium (RhCE) test method for identifying chemicals not requiring classification and labelling for eye irritation or serious eyedamage.

Others

Egg

High Precision ▶ Utilize our sensitive and accurate HET-CAM assay for precise irritancy evaluations without live animals.
Quick Results ▶ Achieve faster assessments with our efficient HET-CAM technique, streamlining the testing process.
Ethical Approach ▶ Our egg-based HET-CAM assay minimizes animal use, aligning with ethical research practices.


Organism	Egg
Product Type	Other
Tissue	Other
Disease

Applications

In vitro eye irritation test (HET-CAM)

The assessment of the degree of irritation is conducted by observingthe visual changes that occur when a test substance is applied to the chorioallantoic membrane of a fertilized.

Others

Zebrafish

Rapid Phenotypic Analysis ▶ Leverage our zebrafish models for swift and accurate phenotypic screenings, reducing time from discovery to results.
High-Throughput Capability ▶ Benefit from our ability to handle large-scale experiments efficiently, enabling extensive screenings within minimal time.
Cost-Effective Solution ▶ Utilize our zebrafish models to conduct comprehensive research at a fraction of the cost compared to mammalian models, without sacrificing quality.


Organism	Fish
Product Type	Other
Tissue	Other
Disease

Applications

Parkinson’s disease model

The enhanced mobility effects of candidate substances, as well as their neuroprotective effects on dopaminergic neurons, can be validated within a two-week period through in vivo behavioral and tissue expression phenotyping

Epilepsy model

The anti-seizure effects of the candidate substance can be validated within a two-week period through in vivo behavioral and electroencephalographic (EEG) phenotyping.

Anxiety & depression model

The antidepressant and anxiolytic effects of the candidate substance can be validated within a two-week period through in vivo behavioral phenotyping

Cancer model